(Q43875206)

27 November 2017

title

Potentiation of liposome-induced complement activation by surface-bound albumin (English)

1 reference

27 November 2017

Sandor Savay

1

1 reference

27 November 2017

Janos Szebeni

series ordinal

2

1 reference

27 November 2017

Lajos Baranyi

series ordinal

3

1 reference

27 November 2017

Carl R Alving

series ordinal

4

1 reference

27 November 2017

publication date

1 February 2002

1 reference

Biochimica et Biophysica Acta

27 November 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

27 November 2017

volume

1559

1 reference

27 November 2017

issue

1

1 reference

27 November 2017

page(s)

79-86

1 reference

Interactions of liposomes with serum proteins.

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900408-4

Influence of dose on liposome clearance: critical role of blood proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900408-4

Hydrophobic free energy, micelle formation and the association of proteins with amphiphiles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900408-4

Activation of glucose diffusion from egg lecithin liquid crystals by serum albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900408-4

Complement activation in vitro by the red cell substitute, liposome-encapsulated hemoglobin: mechanism of activation and inhibition by soluble complement receptor type 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900408-4

Complement activation in human serum by liposome-encapsulated hemoglobin: the role of natural anti-phospholipid antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900408-4

Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900408-4

Studies on HBsAg binding with polymerised human serum albumin by ELISA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900408-4

Antibodies specific for human albumin function as blocking antibodies when attached to erythrocyte-bound albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900408-4

Blocking antibodies specific for human albumin interfere with the hemolytic activity of the membrane attack complex of complement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900408-4

Phagocytosis and degradation of human serum albumin microspheres and nanoparticles in human macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900408-4

Human serum albumin as a probe for protein adsorption to nanoparticles: relevance to biodistribution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900408-4

Phagocytosis of nanoparticles by human immunodeficiency virus (HIV)-infected macrophages: a possibility for antiviral drug targeting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900408-4

Surface-modified biodegradable albumin nano- and microspheres. II: effect of surface charges on in vitro phagocytosis and biodistribution in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900408-4

Body distribution of fully biodegradable [14C]-poly(lactic acid) nanoparticles coated with albumin after parenteral administration to rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900408-4

Albumin nanospheres as carriers for passive drug targeting: an optimized manufacturing technique

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900408-4

10.1016/S0005-2736(01)00408-4

7 January 2021

Identifiers

DOI

1 reference

27 November 2017

1 reference